← Open Payments lookup

SAMIR ISHAK: Open Payments

NPI 1548257488 · PORTLAND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,770 in 87 payments from 10 companies in 2025. Trend: 2023 $1,028 · 2024 $1,150 · 2025 $1,770

Food & beverage: $1,660Education: $109
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.20$454
E.R. Squibb & Sons, L.L.C.28$402
Teva Pharmaceuticals USA, Inc.13$351
Alkermes, Inc.9$188
Axsome Therapeutics, Inc.5$116
Neurocrine BioSciences, Inc.5$102
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$91
Janssen Pharmaceuticals, Inc1$25
Vanda Pharmaceuticals Inc.1$24
ABBVIE INC.1$16

Products named: COBENFY, ABILIFY ASIMTUFII, UZEDY, ARISTADA, ABILIFY MAINTENA, Auvelity, INGREZZA, REXULTI.

Industry payments across IN — which companies pay providers there.